Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Current Strategies for Optimizing Antithrombotic Therapy in Patients with Chronic Coronary Syndrome: A Dynamic Approach.

TH open : companion journal to thrombosis and haemostasis·2026

Same author

Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplant.

Revista espanola de cardiologia (English ed.)·2026

Same author

Device-Pocket Fat Sampling For Amyloid Screening During Cardiac Device Implantation: A Prospective Study.

European journal of heart failure·2026

Same author

Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same author

Non-Biopsy Diagnosis of ATTR-CM: How Safe Is 'Non-Invasive'?

European journal of heart failure·2026

Same author

Persisting Sex Discrepancies in Short-Term Outcomes of Patients with ST-Segment Myocardial Infarction: Results of the ISACS-STEMI COVID-19 Registry.

Journal of clinical medicine·2026

Same journal

Comparing transcatheter aortic valves: time to look beyond simplistic categorisations.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Concomitant transfemoral aortic and mitral valve replacement.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Same journal

Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 7, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Endomyocardial biopsy.

Enrico Fabris^1,2, Aldostefano Porcari^2,3, Rossana Bussani⁴

¹Interventional Cardiology Unit, Cardiothoracovascular Department, University of Trieste, Trieste, Italy.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

|January 5, 2026

Summary

This summary is machine-generated.

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for heart conditions like myocarditis and cardiomyopathies. Careful patient selection and expert performance are essential to ensure safety and optimize the risk/benefit profile.

More Related Videos

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Experiment Videos

Last Updated: Jan 7, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Area of Science:

Cardiology
Interventional Cardiology
Cardiac Pathology

Background:

Endomyocardial biopsy (EMB) has transitioned from monitoring heart transplant rejection to a gold-standard for diagnosing cardiac disorders.
It is vital for unexplained acute heart failure with hemodynamic compromise.
EMB offers interventional cardiologists a bridge between invasive diagnostics and personalized patient care.

Purpose of the Study:

To review the contemporary use of EMB from an interventional cardiologist's viewpoint.
To provide a practical resource for clinical practice regarding EMB.
To clarify the indications and techniques for performing right and left ventricular EMB.

Main Methods:

Review of current clinical practices and literature on endomyocardial biopsy.
Focus on the interventional cardiologist's perspective.
Examination of safety considerations and risk/benefit profiles.

Main Results:

EMB is fundamental for diagnosing myocarditis, cardiomyopathies, and unexplained heart failure.
Technological advancements are enhancing EMB's integration with non-invasive methods for precise cardiac condition management.
Major complications, though rare (1-5%), underscore the need for correct indications and expertise.

Conclusions:

EMB remains a critical tool for definitive etiological diagnosis in various cardiac conditions.
Optimizing the risk/benefit ratio of EMB relies on appropriate patient selection and procedural expertise.
This review serves as a guide for interventional cardiologists on the contemporary application of EMB.